Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers
Journal of the American Society of Nephrology | Dec 05, 2019
Most read this week
Journal of the American Society of Nephrology | Dec 05, 2019